179 related articles for article (PubMed ID: 34373101)
1. Molecular Pathology of Mature Lymphoid Malignancies.
Ware AD; Davis K; Xian RR
Surg Pathol Clin; 2021 Sep; 14(3):529-547. PubMed ID: 34373101
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathology of Mature Lymphoid Malignancies.
Ware AD; Davis K; Xian RR
Clin Lab Med; 2024 Jun; 44(2):355-376. PubMed ID: 38821649
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
Slack GW
Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma cytogenetics.
Dave BJ; Nelson M; Sanger WG
Clin Lab Med; 2011 Dec; 31(4):725-61, x-xi. PubMed ID: 22118746
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
6. The role of molecular biology in the diagnosis of lymphoid neoplasms.
Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Lymphoid Neoplasms.
Ho C; Kluk MJ
Surg Pathol Clin; 2016 Sep; 9(3):489-521. PubMed ID: 27523974
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow biopsies of patients with hematopoietic and lymphoid disorders - epidemiology, chromosomal aberrations and molecular pathology.
Hehne S; Schäfer SM; Richter P; Geier C; Chen Y; von Deimling A; Petersen I
Pathol Res Pract; 2012 Sep; 208(9):510-7. PubMed ID: 22795690
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics of lymphomas.
Campbell LJ
Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
[TBL] [Abstract][Full Text] [Related]
10. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
[TBL] [Abstract][Full Text] [Related]
11. The role of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis and classification of lymphoproliferative disorders on fine-needle aspiration.
Zhang S; Abreo F; Lowery-Nordberg M; Veillon DM; Cotelingam JD
Cancer Cytopathol; 2010 Apr; 118(2):105-12. PubMed ID: 20340097
[TBL] [Abstract][Full Text] [Related]
12. New approaches to lymphoma diagnosis.
Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
Migliazza A; Lombardi L; Rocchi M; Trecca D; Chang CC; Antonacci R; Fracchiolla NS; Ciana P; Maiolo AT; Neri A
Blood; 1994 Dec; 84(11):3850-60. PubMed ID: 7949142
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization and cytogenetics of hemopoietic malignancies: new developments.
Cherif D; Berger R
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):45-7. PubMed ID: 8511041
[TBL] [Abstract][Full Text] [Related]
15. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
Rossi D; Ciardullo C; Gaidano G
Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
[TBL] [Abstract][Full Text] [Related]
16. Primary cardiac lymphoma: molecular cytogenetic characterization of a rare entity.
Schell AJ; Xu Y; Baetz T; Harrison K; Ropchan G; LeBrun D; Feilotter H
Cardiovasc Pathol; 2009; 18(2):92-9. PubMed ID: 18402841
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
Ma ES
Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.
Nowotny H; Karlic H; Grüner H; Hirsch J; Vesely M; Nader A; Heinz R
Ann Hematol; 1996 May; 72(5):291-301. PubMed ID: 8645741
[TBL] [Abstract][Full Text] [Related]
19. Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node.
Trcić RL; Sustercić D; Kuspilić M; Jelić-Puskarić B; Fabijanić I; Kardum-Skelin I
Coll Antropol; 2010 Jun; 34(2):387-93. PubMed ID: 20698107
[TBL] [Abstract][Full Text] [Related]
20. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
Bogusz AM; Bagg A
Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]